Open original FDA record ↗Recall record
- FDA identifier
- Z-1370-2026
- Company in FDA record
- Medica Corporation
- FDA classification date
- Feb 13, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A systematic positive bias of up to 20% was identified across the reportable potassium range, resulting in false elevation results of patient samples when using Medica s capillary tubes.
Source facts
- Action
- An URGENT FIELD SAFETY NOTICE was sent to consignees on 01/09/25 informing them that potassium results obtained using affected devices in capillary mode may be falsely elevated. The FSN instructed consignees not to report potassium results obtained in capillary mode using affected lots on the Easy Stat Analyzer. The FSN is to be forwarded to end users and to where product was further distributed. Consignees are to contact their local representative with any questions.
- Initiated
- 2025-12-31
- Root cause
- Nonconforming Material/Component
- Distribution
- International distribution to the countries of Russia, Bulgaria, Kazakhstan, Ukraine, Pakistan, Belarus.
- Recall number
- Z-1370-2026
- Recall status
- Open, Classified
- CDRH record ID
- 218230
- FDA classified
- 2026-02-13
- Recall event number
- 98315